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Abstract A large number of protein-protein i teractions involve 
turn or loop regions. The excised linear peptides from these re- 
gions reveal complex conformational averaging. To circumvent 
this motional averaging and to stabilize the l~-turn conformation, 
extensive ffort has been devoted to the design of constrained 
peptidomimetics. Here, we report the three-dimensional solution 
structure of a 12-membered cyclic peptidomimetic. The struc- 
tures were calculated from NMR studies performed in chloroform 
and in water at 263 and 278K, respectively. This 12-membered 
cyclic scaffolding is part of a program to design and to construct 
conformationally stable 13-turn peptidomimetics. The impact of 
the surrounding environment on the conformation of this con- 
strained peptidomimetic s discussed. The general structural fea- 
tures of the cyclic mimetic are retained in both environments; 
however, the formation of a hydrophobic patch in the aqueous 
solvent is evident. 
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considering structures in solution. The ability to design and to 
determine a well-defined stable three-dimensional solution 
structure of a molecule makes an important contribution to our 
basic understanding of structure, protein folding, and the phys- 
iological interactions involving ligands and receptors. 
A large array of cyclic peptides have been studied in solution 
by NMR.  However, the vast majority of NMR studies have 
been performed in non aqueous olvents [6-20]. Many of these 
solution studies are restricted to conformational nalysis based 
on qualitative NOE data, modeling, and molecular dynamics 
(MD). In addition, there is minimal experimental evidence of 
the effect of solvent on the conformational aspects of con- 
strained peptidomimetics. Here, we report the three-dimen- 
sional solution structure of a cyclic peptidomimetic as deter- 
mined by NMR in water and in chloroform. The impact of the 
surrounding environment on the conformation of this con- 
strained peptidomimetic is discussed. 
2. Materials and methods 
1. Introduction 
All physiological processes are directly or indirectly regu- 
lated by ligands, peptides, and proteins through their interac- 
tions with their cognate carbohydrate, protein, or nucleic acid 
receptors. Many interactions are dominated by only a small 
interface for their specific recognition and thus require only a 
few exposed residues. This specificity is the result of a particular 
spatial arrangement of side chain functionality presented in the 
context of a helix, reverse turn, or fl-sheet scaffolding. A large 
number of interactions originate from turn or loop regions 
within the protein. The excised linear peptides from these re- 
gions reveal vast and complex conformational averaging in 
solution. To overcome this averaging, extensive ffort has been 
devoted to the design of constrained peptides and peptide 
mimetics (peptidomimetics). A number of conformational stud- 
ies of turns in peptides and peptidomimetics have been per- 
formed [1-5]. However, the critical role of the solvent environ- 
ment and its effect on conformation cannot be neglected when 
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2.1. Sample preparation 
The constrained peptidomimetics l and 2 (Fig. 1) were synthesized 
and purified as described previously with modifications for the 
side chains [21]. The peptide sequence for the mimetic framework is 
derived from the endogenous opioid pentapeptide, l ucine enkephalin 
(Tyr-Gly-Gly-Phe-Leu) [22]. The sample for NMR spectroscopy was 
prepared by dissolving the peptidomimetic 1 in 100% 2H20 and later 
the lyophilized 2H20 sample was dissolved in 90% JH20/10% 2H20 to 
give sample concentration of~5 mM at pH -3. The pH was measured 
with a glass electrode and was not corrected for isotope effects. The 
peptidomimetic 2 was dissolved in CDC13 at a concentration of 
~5 mM. 
2.2. Acquisition of NMR spectra 
The NMR experiments were performed using a Varian Unity 500 
MHz spectrometer. Spectra were recorded at 0.5, 5, 10, and 25°C with 
the carrier set on the ~H20 or residual HOD at 4.96 ppm for the water 
sample and at -10 and 25°C with the carrier set on the residual CHCI 3 
at 7.26 ppm for the chloroform sample. The 3JHN ~ and 3j~ coupling 
constants were obtained irectly from the resolved proton resonances 
in the 1D spectra. Standard pulse sequences and phase cycling schemes 
were used for the 2QF-COSY [23], ROESY [24], NOESY [25], and 
jump-and-return NOESY [26] experiments with 32 64 scans per t~ value 
and 450-800 t~values. Low-power irradiation of the solvent resonance 
during the relaxation delay of 1.4-1.5 s was used for all experiments in 
water with the exception of jump and return NOESY. ROE buildup 
curves were obtained for mixing times of 150, 200, 300, 400, 450, and 
600 ms for water sample and 100, 150, 200, 250, and 300 ms for 
chloroform sample. From the evaluation of the buildup curves, the data 
from the 200 ms ROESY spectrum was then chosen for the generation 
of constraints. All 2D spectra were acquired with 2048 complex data 
points and a spectral width of 5,000-6,250 Hz in F2 and 4,000-5,000 
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Hz in F~. Spectra were recorded in the phase-sensitive mode with 
quadrature detection in the F~ dimension using the methods of States 
and Haberkorn [27]. 
2.3. NMR data processing 
All NMR data were transferred to a Silicon Graphics Iris Indigo 
2/XZ and processed using the program FELIX (BIOSYM Technolo- 
gies, Inc.). NOESY, jump and return NOESY, and ROESY spectra 
were Fourier transformed using a Lorentzian-to-Gaussian weighting 
function in the F2 dimension and a shifted sine bell weighting function 
in the F~ dimension. For 2QF-COSY data, unshifted sine bell and 
shifted sine bell weighting functions for F 2 and F t dimensions were 
used, respectively. For spectra recorded in 90% IH20/10% 2H20, a low 
frequency-deconvolution was applied to the time domain data prior to 
Fourier transformation in order to reduce the size of the residual ~H20 
[28]. The transformed spectra contained 2,048 real points in both di- 
mensions. 
2.4. Structure calculation 
The ROE cross peaks were assigned and interproton distances were 
calculated from the cross peak volumes in the ROESY spectra under 
the rigid body approximation where a single correlation time rc was 
assumed for all interaction vectors. The interproton distances d,j were 
calculated using 
dij = dref (ROE=r/ROEij) 6 
where drer is a known distance between two protons used for calibration 
and ROErer is the corresponding cross peak volume. Lower bounds 
were set to the sum of their van der Waals radii between on-bonded 
atoms. Upper and lower bounds for the ~0 andz1 dihedral angles were 
assigned by inspection of the values of the 3JHNc~ [29] and 3j7~ [30] 
coupling constants. Pseudoatoms were used wherever necessary [31]. 
ROE derived distance constraints, anti-distance onstraints (adc) [32], 
and dihedral angle constraints were used in the structure calculations. 
The adc were derived from analysis of missing cross peaks, leading to 
a list of absent distance constraints. In this study, an absent cross peak 
is attributed to a lower bound or a minimum distance of 4.0 f~ for 
explicit proton distances and 3.0 ,~, whenever a psuedoatom is involved. 
In addition, floating chirality for chemically inequivalent fl-methylene 
and methyl group protons were used wherever appropriate. For pep- 
tidomimetic 1 in water, 45 ROE distance constraints, 2 dihedral angle 
constraints, and 193 adc were used as input data for structural calcula- 
tion. For peptidomimetic 2 in chloroform, 39 ROE, 1 dihedral con- 
straints, and 97 adc were used. Additionally, similar results were 
obtained when structure calculations were carried out without adc. 
During DGII/SA and energy minimization, a force constant of 32 kcal/ 
mol./~2 was used for the half-parabolic NOE and adc penalty func- 
tions. 
Distance geometry calculations were carried out using the program 
DGII (BIOSYM Technologies, Inc., San Diego). The bounds for the 
inter-atomic distances were smoothed by using triangular inequality 
and 20 structures were embedded in4D space, followed by optimization 
using a simulated annealing protocol with sigmoidal cooling schedule 
from a maximum temperature of 200 K in 20,000 steps at simulation 
steps of 2 fs. All peptide bonds were allowed to rotate freely during the 
optimization to account for the highly strained nature of the small cyclic 
peptidomimetic. The structures were then energy minimized using DIS- 
COVER class II cff91 force field with NMR constraints. 
3. Results and discussion 
The NMR studies of 1 and 2 (Fig. 1) were performed in water 
and in chloroform at 278 and 263 K, respectively. Sequence- 
specific resonance assignments were made by standard methods 
from homonuclear  two-dimensional spectra [33]. The 12-mem- 
bered cyclic scaffolding is part of a series in our continuing 
program to design and to synthesize conformational ly stable 
fl-turn peptidomimetics [2,34-36]. The NMR spectra of the 
constrained mimetics display wide chemical shift dispersion, a
characteristic common to a folded protein (Table 1). In partic- 
ular, the C a and C ~ protons of the Leu residue in water show 
chemical shifts significantly different from random coil values 
[37]. The chemical shift difference of 0.28 for C ~ and 0.11 and 
0.22 ppm for C ~ protons for this residue indicate a possible 
presence of structure and/or interaction with an aromatic resi- 
due. The importance of deviation of IH NMR chemical shifts 
from the random-coi l  values for urea-unfolded 434 repressor 
[38,39] and denatured BPTI [40] have been implicated in the 
identity of residual non- random structure. Furthermore,  the 
identity, location, and solution conformation of the structured 
region in the urea-denatured 434 repressor was guided by the 
chemical shift data in combinat ion with amide exchange. 
In both solvents, we observe a very strong ROE between the 
C a protons of Phe and Leu, indicative of a cis-peptide bond at 
the tertiary amide linkage. The ROE between sequential C a 
protons is observed only in the 12-membered gem-dimethyl 
l inker containing structure but not in the analogous 10- and 
14-membered and 12-membered mono-methyl  l inker contain- 
ing cyclic scaffolding (unpubl ished results; M.S.L, Bolong Cao, 
Jan Urban,  M.K., and H.N.). The other key ROE is the obser- 
vation of interaction between the Phe and Leu side chains 
indicating hydrophobic lustering in water. While the chemical 
shift of the Leu protons differ from that of the random coil 
shift, the difference in magnitude reflects the averaging with 
other conformat ion that give rise to the ROE. Thus, it is not 
easy to determine the populat ion of one conformer giving rise 
to one specific ROE. Wiithrich and co-workers [39] have ad- 
dressed this issue and reported that NOESY cross peaks would 
be detectable if the populat ion of the folded conformation were 
at least -10%. With the possible hydrophobic lustering effect 
and the observation of a cis-peptide bond, structure calculation 
was carried out. 
The three-dimensional solution structures of I and 2 in water 
and chloroform, respectively, have been determined based on 
NMR data using the program DGI I /SA followed by energy 
C-Terminus 
N-Terminus /N w CHs 
NHR O~ / ~H.  \ /-°,. 
HsClm'"4k O HsC CHS ) . , , . , I I  
1. R=Tyr 
2. R=H 
Fig. 1. Chemical structure of 12-membered cyclic enkephalJn pep- 
tidomimetic. For clarity normal amino-acid convention was used for 
this peptide mimetic. The 'm' before the three letter code for each 
amino acid stands for 'mimetic' of that amino-acid. Regardless of the 
hetero-atom type in the 'mimetic' amino acid, the position of each 
hetero-atom corresponds to the N, C a, and C' hetero-atoms of the 
normal amino acid. 
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minimization. Solution conformations of cyclic enkephalin an- 
alogues have previously been studied in different solvents by 
the combined use of molecular mechanics conformational nal- 
ysis, NOE, and molecular dynamics [20,4143]. However, to 
our knowledge, this is one of the first cases where structures of 
this type and size were calculated in both aqueous and organic 
solvent. The structures were calculated using torsion angles, 
distance constraints derived from ROESY experiments, and 
anti-distance constraints (adc) [32]. In each case, 20 structures 
were calculated. The total energy for all 20 three-dimensional 
solution structures determined in water ranged from -28.0 to 
29.0 kcal/mol and constraint violation energy of 1.9 to 9.1 
kcal/mol. Only one structure had a positive total energy of 29.0 
kcal/mol which also had the highest constraint violation energy 
of 9.1 kcal/mol. In chloroform, the total energy for all 20 struc- 
tures ranged from -11.8 to 9.0 kcal/mol and constraint viola- 
tion energy of 2.1 to 6.3 kcal/mol. The structures were selected 
based on a 20 kcal/mol cutoff of total energy and less than 4.0 
kcal/mol constraint violation energy from the lowest energy 
structure. In total, 14 structures from chloroform and 15 struc- 
tures from water data were chosen for further analysis. The 
energies for 14 best three-dimensional solution structures calcu- 
lated in chloroform range from -11.8 to -1.3 kcal/mol with a 
mean of -5.8 + 3.3 and 2.1 to 4.0 kcal/mol with a mean of 
2.8 + 0.7 for total and constraint violation energies, respec- 
tively. The energies for the 15 best solution structures in water 
range from -28.0 to -10.2 kcal/mol with mean o f -21 .6  + 5.7 
and 1.9 to 3.8 kcal/mol with a mean of 2.7 _+ 0.7 for total and 
constraint violation energies, respectively. The rms deviation 
was calculated based on all heavy atoms within the cyclic sys- 
tem. In chloroform, the two distinct families exist within the 14 
structures with rmsd of 0.23 A. The two families differ princi- 
pally in the puckering of  the gem-dimethyl group in the linker 
region (Fig. 2a). The 15 best structures in water with an average 
rmsd of 0.29 A are shown in Fig. 2b. All structures in both 
solvents display a cis-peptide bond between the Phe and 
116 M.S. Lee et aL/FEBS Letters 359 (1995) 113-118 
it 
N-Term Linker ~Te~,j 
4 
N-Term 
4 
Linker /~Ter~'l 
N-Term ~ ~ N-Term ~, , ,~  /~. 
4 \ I L inker~ ~ 
b 
1 
Fig. 2. Stereoview of the solution structures of peptidomimetic (a)in chloroform (magenta) nd (b) in water (green). The 14 solution structures in
chloroform (top) is shown with gem-dimethyl linker facing the back while the Phe residue is up front pointing down. All 15 structures calculated 
from water data are shown (bottom) in a similar orientation as the chloroform structures. 
total hydrophilic SASA is increased from 77.2 ,~2 in chloroform 
to 84.8 A 2 in water. In water, the side chain of the Phe rotates 
from the 180 ° to +60 ° conformation sothat the side chains of 
Phe and Leu, the gem-dimethyl group of the linker, and the C- 
terminal N-methyls collapse together to form a hydrophobic 
patch. Concomitantly, this Phe side chain rotation exposes the 
carbonyl and amide groups of the peptide bond between the 
mGly and Phe residues (0.6 ~2 in chloroform to 15.7 A 2 in 
water) and carbonyl oxygen of Phe (0.0 A 2 in chloroform to 4.0 
,~2 in water) to the aqueous environment. A similar observation 
was made during NMR restrained molecular dynamic simula- 
tions of the cyclic octapeptide hymenistatin 1 in chloroform and 
DMSO solutions [15]. The SASA of the carbonyl oxygen at 
Pro-5 of hymenistatin 1 was reduced in DMSO (1.6 ~2 in 
DMSO compared to 5.2 ~2 in chloroform). In contrast, the 
amide nitrogen of Leu-6 which was completely buried in chlo- 
roform became xposed in DMSO due to a favorable H-bond 
interaction i  this solvent. 
4. Conclusions 
We have determined the three-dimensional solution structure 
of a 12-membered constrained peptidomimetic in both chloro- 
form and water. Key structural feature of this cyclic mimetic 
include the solvent independent cis-peptide bond which is con- 
trolled by the linker and the formation of a hydrophobic patch 
in water. The hydrophobic clustering observed in water may 
well represent an accurate description of the conformational 
effects induced on peptides by bulk polar solvent. A similar 
conclusion was derived through the computer simulation study 
of a cyclic hexapeptide that displayed a hydrophobic clustering 
between the Phe and Leu residues as a key structural driving 
force [48]. Statistical analysis of residue associations in protein 
structures have shown a high propensity for interactions be- 
tween Leu and Phe residues [49,50]. Moreover, Kelley and 
co-workers have implicated hydrophobic clustering as a neces- 
sary event in fl-sheet nucleation from their mimetic framework 
[51]. These observations are also consistent with the view of 
hydrophobic collapse as a dominant force in protein folding 
[52]. The effect of environment, hydrophobic clustering, and 
surface hydrophobicity have all been shown to be important 
factors in conformation, ucleation, protein folding, and pro- 
tein-ligand interactions [15,19,39,40,48,51-59]. We have di- 
rectly demonstrated that the environment plays a critical role 
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Fig. 3. View of the solvent accessible surface area of structure (a) in water and (b) in chloroform with hydrophobic surface in gray and hydrophilic 
surface in red. The structure in water shows scattered patches of hydrophilic surface area exposed to the environment in order to maximize hydrogen 
bond interaction with solvent, water. In contrast, in chloroform there is only one strip of hydrophilic surface area. Side chains of Leu, Phe, and 
gem-dimethyl groups form a compact hydrophobic surface in water while in chloroform, the side chain of Phe protrudes out and is exposed to solvent. 
in conformat ional  and structural aspects of even highly con- 
strained molecules in solution. 
Acknowledgments: We gratefully acknowledge the generous financial 
support of the Camille and Henry Dreyfus Foundation (M.K.), and the 
assistance of Kathy Hjelmeland and Melody Ferguson in the prepara- 
tion of this manuscript. M.K. is an Established Investigator of the 
American Heart Association. 
References 
[1] Greer, J., Erickson, J.W., Baldwin, J.J. and Varney, M.D. (1994) 
J. Med. Chem. 37, 1035 1054. 
[2] Kahn, M. (1993) SYNLETT, 821-826. 
[3] Olson, G.L. et al. (1993) J. Med. Chem. 36, 3039 3049. 
[4] Wiley, R.A. and Rich, D.H. (1993) Med. Res. Rev. 13, 327 384. 
[5] Giannis, A. and Kolter, T. (1993) Angew. Chem. Int. Ed. Engl. 32, 
1244~1267. 
[6] Nikiforovich, G.V., Kao, J.L.-F., Plucinska, K., Zhang, W.J. and 
Marshall, G.R. (1994) Biochemistry 33, 3591-3598. 
[7] Bach, A.C.I., Eyermann, C.J., Gross, J.D., Bower, M.J., Harlow, 
R., Weber, P.C. and DeGrado, W.F. (1994) J. Am. Chem. Soc. 
116, 3207-3219. 
[8] Bartosz-Bechowski, H., Davis, P., Zalewska, T., Slaninova, J., 
Porreca, F., Yamamura, H.I. and Hruby, V.J. (1994) J. Med. 
Chem. 37, 14(~150. 
[9] Barrow, C.J., Doleman, M.S., Bobko, M.A. and Cooper, R. (1994) 
J. Med. Chem. 37, 356 363. 
[10] Ali, F.E. et al. (1994) J. Med. Chem. 37, 769-780. 
[1 I] Smythe, M.L. and von Itzstein, M. (1994) J. Am. Chem. Soc. 116, 
2725 2733. 
[12] Fujikawa, A. et al. (1994) J. Org. Chem. 59, 57(~578. 
[13] Jackson, S. et al. (1994) J. Am. Chem. Soc. 116, 322~3230. 
[14] Lomize, A.L., Flippen-Anderson, J.L, George, C. and Mosberg, 
H.I. (1994) J. Am. Chem. Soc. 116, 429-436. 
[15] Konat, R.K., Mierke, D.F., Kessler, H., Kutscher, B., Bernd, M. 
and Voegeli, R. (1993) Helv. Chim. Acta 76, 1649-1666. 
[16] Matsunaga, T.O., Collins, N., Ramaswami, V., Yamamura, S.H., 
O'Brien, D.F. and Hruby, V.J. (1993) Biochemistry 32, 13180- 
13189. 
[17] Bienstock, R.J., Rizo, J., Koerber, S.C., Rivier, J.E., Hagler, A.T. 
and Gierasch, L.M. (1993) J. Med. Chem. 36, 3265 3273. 
[18] Polinsky, A., Cooney, M.G., Toy-Palmer, A., Osapay, G. and 
Goodman, M. (1992) J. Med. Chem. 35, 4185-4194. 
[19] K6ck, M., Kessler, H., Seebach, D. and Thaler, A. (1992) J. Am. 
Chem. Soc. 114, 2676-2686. 
[20] Hruby, V.J., Kao, L.-F., Pettitt, B.M. and Karplus, M. (1988) 
J. Am. Chem. Soc. 110, 3351-3359. 
[21] Gardner, B., Nakanishi, H. and Kahri, M. (1993) Tetrahedron 49, 
3433 3448. 
[22] Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., 
Morgan, B.A. and Morris, H.R. (1975) Nature 258, 577 579. 
[23] Rance, M., Sorensen, O.W., Bodenhausen, G., Wagner, G., Ernst, 
R.R. and W~ithrich, K. (1983) Biochem. Biophys. Res. Commun. 
117, 479-485. 
[24] Kessler, H., Griesinger, C., Kerssebaum, R., Wagner, K. and 
Ernst, R.R. (1987) J. Am. Chem. Soc. 109, 607 609. 
[25] Jeener, J., Meier, B.H., Bachmann, P. and Ernst, R.R. (1979) 
J. Chem. Phys. 71, 45464553. 
[26] Bax, A., Sklenar, V., Clore, G.M. and Gronenborn, A.M. (1987) 
J. Am. Chem. Soc. 109, 6511 6513. 
[27] States, D.J., Habekorn, R.A. and Ruben, D.J. (1982) J. Magn. 
Reson. 48, 286292. 
[28] Marion, D. and Wtithrich, K. (1983) Biochem. Biophys. Res. 
Commun. 113, 967-974. 
[29] Pardi, A., Billeter, M. and Wiithrich, K. (1984) J. Mol. Biol. 180, 
741-751. 
118 M.S. Lee et al . /FEBS Letters 359 (1995) 113-118 
[30] Nagayama, K. and Wfithrich, K. (1981) Eur. J. Biochem. 115, 
653-657. 
[31] Wfithrich, K., Billeter, M. and Braun, W. (1983) J. Mol. Biol. 169, 
949-961. 
[32] Briischweiler, R.E, Blackledge, M. and Ernst, R.R. (1991) 
J. Biomol. NMR 1, 3 11. 
[33] Wfithrich, K. (1986) NMR of Proteins and Nucleic Acids, Wiley, 
New York. 
[34] Ramurthy, S., Lee, M.S., Nakanishi, H., Shen, R. and Kahn, M. 
(1994) Bioorg. Med. Chem. 2, 1007-1013. 
[35] Nakanishi, H., Chrusciel, R.A., Shen, R., Bertenshaw, S., 
Johnson, M.E., Rydel, T.J., Tulinsky, A. and Kahn, M. (1992) 
Proc. Natl. Acad. Sci. USA 89, 1705-9. 
[36] Chen, S. et al. (1992) Proc. Natl. Acad. Sci. USA 89, 5872-5876. 
[37] Bundi, A. and Wiithrich, K. (1979) Biopolymers 18, 285 297. 
[38] Neri, D., Wider, G. and Wfithrich, K. (1992) Proc. Natl. Acad. Sci. 
89, 4397-4401. 
[39] Neri, D., Billeter, M., Wider, G. and Wfithrich, K. (1992) Science 
257, 1559-1563. 
[40] Lumb, K.J. and Kim, P.S. (1994) J. Mol. Biol. 236, 412-420. 
[41] Graham, W.H., Carter, E.S., II and Hicks, R.E (1992) Biopoly- 
mers 32, 1755. 
[42] Mierke, D., Said-Nejad, O.E., Schiller, P.W. and Goodman, M. 
(1990) Biopolymers 29, 179-196. 
[43] Schmidt, R., Vogel, D., Mrestani-Klaus, C., Brandt, W., Neubert, 
K., Chung, N.N., Lemieux, C. and Schiller, P.W. (1994) J. Med. 
Chem. 37, 1136-1144. 
[44] Abagyan, R.A. and Totrov, M. (1994) J. Mol. Biol. 235,983-1002. 
[45] Blaber, M., Zhang, X.-J., Lindstrom, J.D., Pepiot, S.D., Baase, 
W.A. and Matthews, B.W. (1994) J. Mol. Biol. 235, 600-624. 
[46] Schrauber, H., Eisenhaber, F. and Argos, P. (1993) J. Mol. Biol. 
230, 592-612. 
[47] Lee, B. and Richards, F.M. (1971) J. Mol. Biol. 55, 379-400. 
[48] Simmerling, C. and Elber, R. (1994) J. Am. Chem. Soc. 116, 
2534-2547. 
[49] Karlin, S., Zuker, M. and Brocchieri, L. (1994) J. Mol. Biol. 239, 
227-248. 
[50] Singh, J. and Thornton, J.M. (1992), Vol. 2, pp. 428-827 IRL 
Press, New York. 
[51] Tsang, K.Y., Diaz, H., Graciani, N. and Kelly, J.W. (1994) J. Am. 
Chem. Soc. 116, 3988-4005. 
[52] Dill, K.A. (1990) Biochemistry 31, 7133 7155. 
[53] Waterhous, D.V. and Johnson, W.C.J. (1994) Biochemistry 33, 
2121 2128. 
[54] Young, L., Jernigan, R.L. and Covell, D.G. (1994) Protein Science 
3, 717 729. 
[55] Lee, B. (1993) Protein Science 2, 733 738. 
[56] Eriksson, A.E., Baase, W.A., Zhang, X.-J., Heinz, D.W., Blaber, 
M., Baldwin, E.P. and Matthews, B.W. (1992) Science 255, 178- 
183. 
[57] Weber, C., Wider, G., von Freyberg, B., Traber, R., Braun, W., 
Widmer, H. and Wiithrich, K. (1991) Biochemistry 30, 6563-6574. 
[58] Evans, EA., Topping, K.D., Woolfson, D.N. and Dobson, C.M. 
(1991) Proteins: Struct. Func. Genet. 9, 248-266. 
[59] Wright, EE., Dyson, H.J. and Lerrler, R.A. (1988) Biochemistry 
27, 7167 7175. 
